- Home
- FTHM vs PYPD Comparison
FTHM vs PYPD Comparison
Compare FTHM & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHM | PYPD |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 81.7M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FTHM | PYPD |
|---|---|---|
| Price | $0.61 | $4.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $2.50 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 114.3K | 51.7K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $420,477,000.00 | N/A |
| Revenue This Year | $18.88 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.45 | N/A |
| 52 Week Low | $0.48 | $2.30 |
| 52 Week High | $3.37 | $5.12 |
Technical Indicators
Market Signals| Indicator | FTHM | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 32.39 | 53.60 |
| Support Level | N/A | $4.14 |
| Resistance Level | $1.49 | $5.05 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 30.34 | 54.96 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.